Quarter Financials

89Bio Inc

89Bio Inc (ETNB)

$25.36
0.94 (+3.85%)

Income Statement

Balance Sheet Statement

Year 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2
Short-term debt -----
Other Assets 0.301.750.100.101.10
Total current liabilities 9.5422.585.617.796.79
Cash and cash equivalents 21.9216.1993.3385.5368.20
Long-term debt -----
Cash and short-term investments 21.9216.1993.3385.5373.90
Total debt -----
Inventories -----
Deferred revenue -----
Goodwill and Intangible Assets -----
Total non-current liabilities -----
Total non-current assets 0.321.770.230.281.27
Total liabilities 9.5422.585.617.796.79
Total assets 22.3518.3595.5587.6976.56
Other comprehensive income -----
Short-term investments ----5.70
Property, Plant & Equipment Net 0.050.050.150.200.19
Net Debt -21.92-16.19-93.33-85.53-68.20
Investments ----5.70
Total shareholders equity 12.81-4.2289.9479.9069.77
Retained earnings (deficit) -35.59-54.31-73.60-84.14-95.91
Long-term investments -----
Receivables -----
Payables -----
Total current assets 22.0316.5995.3387.4175.29

Cash Flow Statement

Year 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2
Operating Cash Flow -6.64-2.53-3.29-4.17-3.96-6.20-11.13-7.75-11.52
Free Cash Flow -6.67-2.54-3.29-4.17-3.98-6.20-11.24-7.81-11.57
Capital Expenditure -0.03-0.00-0.00-0.00-0.02-0.01-0.11-0.06-0.05
Depreciation & Amortization -0.000.000.000.000.010.010.010.02
Acquisitions and disposals ---------
Deferred income taxes ---0.02-0.02-0.03-0.020.09--
Investment purchases ---------
Accounts payables -----1.61-2.133.07-0.94
Sales/Maturities of investments ---------
Change in working capital 0.371.231.030.690.011.92-1.692.29-0.76
Debt repayment ---------
Other non-cash items 0.360.400.33-0.4011.0210.629.750.490.99
Investing Cash Flow -0.03-0.00-0.00-0.00-0.02-0.01-0.11-0.06-5.74
Cash at beginning of period 85.5385.5385.5385.53-21.9216.1993.3385.53
Stock-based compensation -----0.220.170.490.91
Net cash flow / Change in cash 8.10-2.545.71-4.1714.86-5.7277.13-7.80-17.33
Effect of forex changes on cash ---------
Financing Cash Flow 14.77-0.019.00-18.840.4988.380.01-0.07
Dividend payments ---------
Accounts receivables ---------
Cash at end of period 93.6382.9991.2481.3614.8616.2093.3285.5368.20
Net cash provided by operating activities -6.64-2.53-3.29-4.17-3.96-6.20-11.13-7.75-11.52
Other working capital ------5.9989.7279.6368.50
Inventory ---------

Retained Earning Schedule

Year 2019 Q2 2019 Q3 2019 Q4 2020 Q1 2020 Q2
Net Income -19-19-19-11-12
Dividend Paid -----
Retained Earnings -36-54-74-84-96

PPE Schedule

Year 2019 Q2 2019 Q3 2019 Q4 2020 Q1 2020 Q2
Capital Expenditure -0-0-0-0-0
Net PPE 00000

Intangible and Goodwill Schedule

Year 2019 Q2 2019 Q3 2019 Q4 2020 Q1 2020 Q2
New Purchases -----
Intangible and Goodwill -----